The efficacy of hesperidin for treatment of acute otitis media
Copyright © 2018 Elsevier B.V. All rights reserved..
OBJECTIVES: In this experimental study, the effect of hesperidin on the treatment of acute otitis media (AOM) was investigated in an AOM-induced rat model.
METHODS: In total, 35 rats were randomly divided into the following five groups (n=7): group 1 (control), group 2 (AOM with no treatment), group 3 (AOM+antibiotic), group 4 (AOM+hesperidin), and group 5 (AOM+hesperidin+antibiotic). On day 14, group 3,4 and 5 rats were given antibiotic and hesperidin via gavages, respectively. Histopathological and immunological analyses were performed and the results analyzed.
RESULTS: Serum levels of TNF-α, IL-4, IL-6 and IL-1β were significantly decreased in the hesperidin- and antibiotic-treated groups compared to the AOM group. The AOM+antibiotic and AOM+hesperidin groups demonstrated reduced histological damage compared to the AOM group. Between the AOM+antibiotic and AOM+hesperidin groups, significant differences in tympanic membrane thickness(ThicTM), inflammation(Inf), and sclerosis(Sc) values were observed. However, no difference in epithelial damage(DamEpith), was seen between the two groups. There was a significant difference in the AOM+antibiotic and AOM+antibiotic+hesperidin groups compared to AOM group (P<0.001).
CONCLUSIONS: In this study, we observed that both antibiotic and hesperidin treatment reduced AOM symptoms in an AOM-induced rat model. The values in AOM+antibiotic+hesperidin group were markedly lower than those of the other groups. From our results, we propose that hesperidin, in combination with antibiotics, may provide a successful alternative treatment for AOM compared with antibiotics used alone.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2019 |
---|---|
Erschienen: |
2019 |
Enthalten in: |
Zur Gesamtaufnahme - volume:46 |
---|---|
Enthalten in: |
Auris, nasus, larynx - 46(2019), 2 vom: 15. Apr., Seite 172-177 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Cetinkaya, Erdem Atalay [VerfasserIn] |
---|
Links: |
---|
Anmerkungen: |
Date Completed 10.06.2019 Date Revised 13.06.2019 published: Print-Electronic Citation Status MEDLINE |
---|
doi: |
10.1016/j.anl.2018.07.005 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM287117766 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM287117766 | ||
003 | DE-627 | ||
005 | 20231225053312.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231225s2019 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1016/j.anl.2018.07.005 |2 doi | |
028 | 5 | 2 | |a pubmed24n0957.xml |
035 | |a (DE-627)NLM287117766 | ||
035 | |a (NLM)30072162 | ||
035 | |a (PII)S0385-8146(17)30756-3 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Cetinkaya, Erdem Atalay |e verfasserin |4 aut | |
245 | 1 | 4 | |a The efficacy of hesperidin for treatment of acute otitis media |
264 | 1 | |c 2019 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 10.06.2019 | ||
500 | |a Date Revised 13.06.2019 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a Copyright © 2018 Elsevier B.V. All rights reserved. | ||
520 | |a OBJECTIVES: In this experimental study, the effect of hesperidin on the treatment of acute otitis media (AOM) was investigated in an AOM-induced rat model | ||
520 | |a METHODS: In total, 35 rats were randomly divided into the following five groups (n=7): group 1 (control), group 2 (AOM with no treatment), group 3 (AOM+antibiotic), group 4 (AOM+hesperidin), and group 5 (AOM+hesperidin+antibiotic). On day 14, group 3,4 and 5 rats were given antibiotic and hesperidin via gavages, respectively. Histopathological and immunological analyses were performed and the results analyzed | ||
520 | |a RESULTS: Serum levels of TNF-α, IL-4, IL-6 and IL-1β were significantly decreased in the hesperidin- and antibiotic-treated groups compared to the AOM group. The AOM+antibiotic and AOM+hesperidin groups demonstrated reduced histological damage compared to the AOM group. Between the AOM+antibiotic and AOM+hesperidin groups, significant differences in tympanic membrane thickness(ThicTM), inflammation(Inf), and sclerosis(Sc) values were observed. However, no difference in epithelial damage(DamEpith), was seen between the two groups. There was a significant difference in the AOM+antibiotic and AOM+antibiotic+hesperidin groups compared to AOM group (P<0.001) | ||
520 | |a CONCLUSIONS: In this study, we observed that both antibiotic and hesperidin treatment reduced AOM symptoms in an AOM-induced rat model. The values in AOM+antibiotic+hesperidin group were markedly lower than those of the other groups. From our results, we propose that hesperidin, in combination with antibiotics, may provide a successful alternative treatment for AOM compared with antibiotics used alone | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Acute otitis media | |
650 | 4 | |a Cytokines | |
650 | 4 | |a Hesperidin | |
650 | 4 | |a Histological examination | |
650 | 4 | |a Rats | |
650 | 7 | |a Anti-Bacterial Agents |2 NLM | |
650 | 7 | |a Cytokines |2 NLM | |
650 | 7 | |a IL1B protein, rat |2 NLM | |
650 | 7 | |a Il6 protein, rat |2 NLM | |
650 | 7 | |a Interleukin-1beta |2 NLM | |
650 | 7 | |a Interleukin-6 |2 NLM | |
650 | 7 | |a Tumor Necrosis Factor-alpha |2 NLM | |
650 | 7 | |a Interleukin-4 |2 NLM | |
650 | 7 | |a 207137-56-2 |2 NLM | |
650 | 7 | |a Hesperidin |2 NLM | |
650 | 7 | |a E750O06Y6O |2 NLM | |
700 | 1 | |a Ciftci, Osman |e verfasserin |4 aut | |
700 | 1 | |a Alan, Saadet |e verfasserin |4 aut | |
700 | 1 | |a Oztanır, M Namık |e verfasserin |4 aut | |
700 | 1 | |a Basak, Nese |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Auris, nasus, larynx |d 1993 |g 46(2019), 2 vom: 15. Apr., Seite 172-177 |w (DE-627)NLM000465496 |x 1879-1476 |7 nnns |
773 | 1 | 8 | |g volume:46 |g year:2019 |g number:2 |g day:15 |g month:04 |g pages:172-177 |
856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.anl.2018.07.005 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 46 |j 2019 |e 2 |b 15 |c 04 |h 172-177 |